TNFRSF17 and Miyoshi myopathy: Additional bispecific CAR-Ts are in preclinical development, including a BCMA/CD24 CAR-T and a CAR-T directed against BCMA and MICA (human MHC class 1 related chain A gene), which is upregulated by MM cells as an immune evasion tool (115).